X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (48) 48
index medicus (46) 46
oncology (45) 45
cancer (40) 40
male (30) 30
female (29) 29
aged (28) 28
clinical trials (25) 25
middle aged (25) 25
neoplasms - drug therapy (25) 25
research (24) 24
tumors (24) 24
adult (21) 21
medicine & public health (17) 17
drug therapy (16) 16
mutation (16) 16
article (13) 13
pharmacology & pharmacy (13) 13
pharmacology/toxicology (13) 13
dosage and administration (12) 12
studies (12) 12
aged, 80 and over (11) 11
biomarkers (11) 11
care and treatment (11) 11
antineoplastic combined chemotherapy protocols - adverse effects (10) 10
chemotherapy (10) 10
kinases (10) 10
analysis (9) 9
antimitotic agents (9) 9
antineoplastic agents (9) 9
complications and side effects (9) 9
neoplasms - metabolism (9) 9
open-label (9) 9
patients (9) 9
treatment outcome (9) 9
antineoplastic agents - therapeutic use (8) 8
antineoplastic combined chemotherapy protocols - therapeutic use (8) 8
inhibitor drugs (8) 8
pharmacokinetics (8) 8
pharmacology (8) 8
antineoplastic agents - adverse effects (7) 7
breast-cancer (7) 7
cancer therapies (7) 7
cell lung-cancer (7) 7
drug administration schedule (7) 7
maximum tolerated dose (7) 7
medical research (7) 7
metastasis (7) 7
neoplasms - pathology (7) 7
solid tumors (7) 7
therapy (7) 7
cells (6) 6
dose-response relationship, drug (6) 6
head & neck cancer (6) 6
head and neck cancer (6) 6
health aspects (6) 6
neoplasms - genetics (6) 6
young adult (6) 6
antineoplastic agents - administration & dosage (5) 5
antineoplastic agents - pharmacokinetics (5) 5
antineoplastic combined chemotherapy protocols - administration & dosage (5) 5
clinical trials as topic (5) 5
colorectal cancer (5) 5
combination (5) 5
genetic aspects (5) 5
medicine (5) 5
pharmaceutical sciences (5) 5
precision medicine (5) 5
research design (5) 5
resistance (5) 5
agents (4) 4
angiogenesis (4) 4
animals (4) 4
antineoplastic combined chemotherapy protocols - pharmacokinetics (4) 4
area under curve (4) 4
biomarkers, tumor - genetics (4) 4
cisplatin (4) 4
cohort studies (4) 4
continual reassessment method (4) 4
dna, neoplasm - genetics (4) 4
drug development (4) 4
drug dosages (4) 4
drug resistance (4) 4
genetics & heredity (4) 4
genomes (4) 4
genomics (4) 4
human papillomavirus (4) 4
immunotherapy (4) 4
methods (4) 4
molecular biology (4) 4
multicenter (4) 4
neoplasms - epidemiology (4) 4
neoplasms. tumors. oncology. including cancer and carcinogens (4) 4
patient outcomes (4) 4
phase i studies (4) 4
product development (4) 4
prospective studies (4) 4
protein kinase inhibitors - administration & dosage (4) 4
protein kinase inhibitors - adverse effects (4) 4
proteins (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


by Tefferi, Ayalew, MD and Kantarjian, Hagop, MD and Rajkumar, S. Vincent, MD and Baker, Lawrence H., DO and Abkowitz, Jan L., MD and Adamson, John W., MD and Advani, Ranjana Hira, MD and Allison, James, MD and Antman, Karen H., MD and Bast, Robert C., MD and Bennett, John M., MD and Benz, Edward J., MD and Berliner, Nancy, MD and Bertino, Joseph, MD and Bhatia, Ravi, MD and Bhatia, Smita, MD and Bhojwani, Deepa, MD and Blanke, Charles D., MD and Bloomfield, Clara D., MD and Bosserman, Linda, MD and Broxmeyer, Hal E., PhD and Byrd, John C., MD and Cabanillas, Fernando, MD and Canellos, George Peter, MD and Chabner, Bruce A., MD and Chanan-Khan, Asher, MD and Cheson, Bruce, MD and Clarkson, Bayard, MD and Cohn, Susan L., MD and Colon-Otero, Gerardo, MD and Cortes, Jorge, MD and Coutre, Steven, MD and Cristofanilli, Massimo, MD and Curran, Walter J., MD and Daley, George Q., MD, PhD and DeAngelo, Daniel J., MD, PhD and Deeg, H. Joachim, MD and Einhorn, Lawrence H., MD and Erba, Harry P., MD, PhD and Esteva, Francisco J., MD, PhD and Estey, Elihu, MD and Fidler, Isaiah J., DVM, PhD and Foran, James, MD and Forman, Stephen, MD and Freireich, Emil, MD and Fuchs, Charles, MD, MPH and George, James N., MD and Gertz, Morie A., MD and Giralt, Sergio, MD and Golomb, Harvey, MD and Greenberg, Peter, MD and Gutterman, Jordan, MD and Handin, Robert I., MD and Hellman, Samuel, MD and Hoff, Paulo Marcelo, MD and Hoffman, Ronald, MD and Hong, Waun Ki, MD and Horowitz, Mary, MD, MS and Hortobagyi, Gabriel N., MD and Hudis, Clifford, MD and Issa, Jean Pierre, MD and Johnson, Bruce Evan, MD and Kantoff, Philip W., MD and Kaushansky, Kenneth, MD and Khayat, David, MD, PhD and Khuri, Fadlo R., MD and Kipps, Thomas J., MD, PhD and Kripke, Margaret, PhD and Kyle, Robert A., MD and Larson, Richard A., MD and Lawrence, Theodore S., MD, PhD and Levine, Ross, MD and Link, Michael P., MD and Lippman, Scott M., MD and Lonial, Sagar, MD and Lyman, Gary H., MD, MPH and Markman, Maurie, MD and Mendelsohn, John, MD and Meropol, Neal J., MD and Messinger, Yoav, MD and Mulvey, Therese M., MD and O’Brien, Susan, MD and Perez-Soler, Roman, MD and Pollock, Raphael, MD, PhD and Prchal, Josef, MD and Press, Oliver, MD, PhD and Radich, Jerald, MD and Rai, Kanti, MD and Rosenberg, Saul A., MD and Rowe, Jacob M., MD and Rugo, Hope, MD and Runowicz, Carolyn D., MD and Sandmaier, Brenda M., MD and Saven, Alan, MD and Schafer, Andrew I., MD and Schiffer, Charles, MD and Sekeres, Mikkael A., MD, MS and Silver, Richard T., MD and Siu, Lillian L., MD and Steensma, David P., MD and ...
Mayo Clinic Proceedings, ISSN 0025-6196, 2015, Volume 90, Issue 8, pp. 996 - 1000
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2016, Volume 96, Issue 5, pp. 994 - 1002
Purpose Locoregional recurrence is common after surgery for gastric cancer. Adjuvant therapy improves outcomes but with toxicity. This phase 1/2 study... 
Radiology | Hematology, Oncology and Palliative Medicine | SURGERY | GASTROESOPHAGEAL CANCER | METAANALYSIS | LYMPHADENECTOMY | ONCOLOGY | ADENOCARCINOMA | CHEMORADIATION | CHEMORADIOTHERAPY | QUALITY-OF-LIFE | RADIOTHERAPY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | III TRIAL | Medication Adherence - statistics & numerical data | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Stomach Neoplasms - pathology | Antineoplastic Agents - administration & dosage | Radiotherapy, Image-Guided | Neoplasm Recurrence, Local - mortality | Cisplatin - administration & dosage | Fluorouracil - administration & dosage | Radiation-Sensitizing Agents - administration & dosage | Antineoplastic Agents - adverse effects | Adult | Female | Drug Administration Schedule | Stomach Neoplasms - therapy | Radiation-Sensitizing Agents - adverse effects | Chemoradiotherapy, Adjuvant - methods | Maximum Tolerated Dose | Cisplatin - adverse effects | Quality of Life | Aged | Stomach Neoplasms - surgery | Stomach Neoplasms - mortality | Care and treatment | Radiation | Adjuvant treatment | Radiotherapy | Health aspects | Stomach cancer | Cisplatin | Cancer | Fluorouracil | Index Medicus | PATIENTS | NEOPLASMS | IMAGES | MAGNESIUM 40 | RADIOLOGY AND NUCLEAR MEDICINE | RADIATION DOSES | TOXICITY | FLUORINE COMPOUNDS | GY RANGE 10-100 | CHEMOTHERAPY
Journal Article
Journal Article
Leukemia & Lymphoma, ISSN 1042-8194, 10/2015, Volume 56, Issue 10, pp. 2793 - 2802
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 09/2017, Volume 23, Issue 17, pp. 4950 - 4958
Immunotherapy adds an exciting new dimension to the treatment of cancer, joining other approaches as a key pillar in the oncotherapeutics armamentarium.... 
CELL LUNG-CANCER | CHECKMATE 032 | MULTICENTER | PEMBROLIZUMAB | RESPONSE CRITERIA | ONCOLOGY | STATISTICAL CONTROVERSIES | NIVOLUMAB MONOTHERAPY | TUMOR RESPONSE | OPEN-LABEL | PHASE-I | Medical research | Toxicity | Clinical trials | Oncology | Anticancer properties | Design | Immunotherapy | Reagents | Biomarkers | Antitumor activity | Kinetics | Cancer | Immune system | Index Medicus
Journal Article
Journal of Hematology and Oncology, ISSN 1756-8722, 01/2014, Volume 7, Issue 1, pp. 1 - 1
Background: Inhibition of AKT with MK-2206 has demonstrated synergism with anticancer agents. This phase 1 study assessed the MTD, DLTs, PK, and efficacy of... 
Chemotherapy | AKT inhibitor | Protein serine-threonine kinase | MK-2206 | Phase 1 | Solid tumors | Combination therapy | TARGET | ACTIVATION | PKB/AKT | LUNG-CANCER CELLS | PI3K/AKT PATHWAY | PHARMACOKINETICS | ONCOLOGY | RESISTANCE | HEMATOLOGY | Erlotinib Hydrochloride | Neoplasms - metabolism | Nausea - chemically induced | Area Under Curve | Febrile Neutropenia - chemically induced | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Fatigue - chemically induced | Carboplatin - adverse effects | Dose-Response Relationship, Drug | Young Adult | Tinnitus - chemically induced | Exanthema - chemically induced | Adult | Female | Quinazolines - administration & dosage | Heterocyclic Compounds, 3-Ring - pharmacokinetics | Paclitaxel - administration & dosage | Proto-Oncogene Proteins c-akt - metabolism | Taxoids - adverse effects | Administration, Oral | Carboplatin - administration & dosage | Paclitaxel - adverse effects | Neoplasms - classification | Treatment Outcome | Neoplasms - drug therapy | Taxoids - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Heterocyclic Compounds, 3-Ring - administration & dosage | Heterocyclic Compounds, 3-Ring - adverse effects | Stomatitis - chemically induced | Quinazolines - adverse effects | Aged | Proto-Oncogene Proteins c-akt - antagonists & inhibitors | Skin diseases | Product development | Pharmaceutical industry | Cancer | Medical research | Cell growth | Data analysis | Biomedical research | Writing | Mutation | Kinases | Drug dosages | Tumors | Apoptosis
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 03/2011, Volume 29, Issue 7, pp. 934 - 943
Journal Article
Genome Medicine, ISSN 1756-994X, 10/2016, Volume 8, Issue 1, pp. 109 - 12
Journal Article